Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 10694544

Low-dose 5-aza-2'-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase II study in elderly patients.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2000 Mar
First author
Wijermans P

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Wijermans P
      type
      Author
    2. name
      Lübbert M
      type
      Author
    3. name
      Verhoef G
      type
      Author
    4. name
      Bosly A
      type
      Author
    5. name
      Ravoet C
      type
      Author
    6. name
      Andre M
      type
      Author
    7. name
      Ferrant A
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Wijermans P
      type
      Author
    2. name
      Lübbert M
      type
      Author
    3. name
      Verhoef G
      type
      Author
    4. name
      Bosly A
      type
      Author
    5. name
      Ravoet C
      type
      Author
    6. name
      Andre M
      type
      Author
    7. name
      Ferrant A
      type
      Author
    bibliography ids
    1. nci-bib-7ca21c4b4bb1043d74289729
    book metadata
    content sha256
    874c3928bf43b7419dc674db3d1d3ce1d6e1cee75189c128732bab03a4e185e7
    document type
    citation
    dois
    1. 10.1200/JCO.2000.18.5.956
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:10694544
    immutable id
    pubmed:10694544@874c3928bf43b7419dc674db3d1d3ce1d6e1cee75189c128732bab03a4e185e7
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    Source null
    issn print
    0732-183X
    issue
    5
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    956-62
    volume
    18
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      10694544
      provenance
      batch id
      40703d4bdd5a70d2c67a
      provider
      NCBI PubMed ESummary
      record sha256
      798f295ecc680276c3e919b94b1d69612ae119b3728c682a75639a7e4b15d57c
      response sha256
      a3c61c2ff7d134e39b75494c75710402933a0e6adc127aa6cbdffc11682a963b
      retrieved at
      2026-09-09T23:45:35.800055+00:00
      publication date
      display
      2000 Mar
      precision
      month
      year
      2000
      publication types
      1. Clinical Trial
      2. Clinical Trial, Phase II
      3. Journal Article
      4. Multicenter Study
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/10694544/
      title
      Low-dose 5-aza-2'-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase II study in elderly patients.

      Preserved source evidence · Not medical advice